- Home
- AMTM vs BPMC Comparison
AMTM vs BPMC Comparison
Compare AMTM & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTM
- BPMC
- Stock Information
- Founded
- AMTM 2020
- BPMC 2008
- Country
- AMTM United States
- BPMC United States
- Employees
- AMTM N/A
- BPMC N/A
- Industry
- AMTM
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- AMTM
- BPMC Health Care
- Exchange
- AMTM NYSE
- BPMC Nasdaq
- Market Cap
- AMTM 5.6B
- BPMC 5.8B
- IPO Year
- AMTM N/A
- BPMC 2015
- Fundamental
- Price
- AMTM $24.21
- BPMC $128.35
- Analyst Decision
- AMTM Buy
- BPMC Buy
- Analyst Count
- AMTM 6
- BPMC 20
- Target Price
- AMTM $25.50
- BPMC $127.82
- AVG Volume (30 Days)
- AMTM 2.2M
- BPMC 3.6M
- Earning Date
- AMTM 08-05-2025
- BPMC 07-31-2025
- Dividend Yield
- AMTM N/A
- BPMC N/A
- EPS Growth
- AMTM N/A
- BPMC N/A
- EPS
- AMTM 0.10
- BPMC N/A
- Revenue
- AMTM $11,261,000,000.00
- BPMC $562,121,000.00
- Revenue This Year
- AMTM $70.67
- BPMC $44.46
- Revenue Next Year
- AMTM $2.35
- BPMC $32.78
- P/E Ratio
- AMTM $253.45
- BPMC N/A
- Revenue Growth
- AMTM 38.56
- BPMC 99.19
- 52 Week Low
- AMTM $16.01
- BPMC $73.04
- 52 Week High
- AMTM $34.50
- BPMC $128.52
- Technical
- Relative Strength Index (RSI)
- AMTM N/A
- BPMC 74.59
- Support Level
- AMTM N/A
- BPMC $128.06
- Resistance Level
- AMTM N/A
- BPMC $128.52
- Average True Range (ATR)
- AMTM 0.00
- BPMC 0.28
- MACD
- AMTM 0.00
- BPMC -1.18
- Stochastic Oscillator
- AMTM 0.00
- BPMC 74.44
About AMTM AMENTUM HOLDINGS INC
Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.